拥抱技术来开发临床药理学和药物安全在本科医学教育的选修课程
William T Wightkin1, Elizabeth B Graham2, Brooke Hooper3
1Department of Biomedical and Translational Sciences, Eastern Virginia Medical School, 700 W. Olney Rd., Norfolk, VA 23507 USA.
Medical science educator
|January 6, 2025
概括
为医学学生开发了一个新的临床药理学和药物安全课程. 这个选修课使用视频会议来改善药理学教育和减少药物错误.
科学领域:
- 医学教育 医学教育
- 临床药理学 临床药理学
- 患者安全 患者安全
背景情况:
- 基础药理学知识对于医学学生至关重要.
- 预防药物错误是患者安全的一个关键方面.
- 传统的课程可以从创新的教学方法中受益.
研究的目的:
- 为医学四年级学生开发和评估临床药理学和药物安全选修课程.
- 为了提高学生对药理学和药物错误预防的理解.
- 探索使用技术进行跨专业和多机构合作.
主要方法:
- 临床药理学和药物安全选修课程是为医学四年级学生设计的.
- 视频会议技术被用来提供课程内容.
- 该选修课旨在垂直整合药理学课程,并促进合作.
主要成果:
- 选修课增强了学生的基础药理学知识.
- 学生们更好地了解了预防药物错误的方法.
- 视频会议促进了多机构和专业间的合作.
结论:
- 临床药理学和药物安全选修课可以有效地改善医学学生的教育.
- 视频会议是药理学课程交付的一个可行的现代方法.
- 通过技术加强合作可以改善学生在药理学和安全方面的学习成果.
相关概念视频
Pharmacovigilance
730
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
730
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Drug Administration and Therapy Phases: Overview
368
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
368
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K


